TWST
Twist Bioscience Corp
NASDAQ: TWST · HEALTHCARE · DIAGNOSTICS & RESEARCH
$56.70
-4.14% today
Updated 2026-04-29
Market cap
$3.48B
P/E ratio
—
P/S ratio
8.88x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$23 – $66
Volume
1.2M
Twist Bioscience Corp (TWST) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $76.46M | $85.66M | $115.79M | $186.99M | $398.88M | $702.10M | $961.38M | $776.40M | $614.32M | $641.86M |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — |
| Current assets | $59.04M | $67.87M | $95.67M | $160.13M | $334.87M | $546.50M | $596.48M | $424.26M | $346.78M | $332.97M |
| Total liabilities | $153.07M | $219.01M | $317.21M | $34.91M | $62.62M | $121.28M | $171.99M | $152.97M | $141.63M | $168.90M |
| Current liabilities | $8.68M | $9.48M | $18.54M | $30.35M | $36.03M | $63.05M | $90.66M | $73.32M | $71.01M | $91.41M |
| Long-term debt | $9.81M | $9.15M | $7.22M | $4.40M | $1.40M | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-80.31M | $-139.62M | $-210.85M | $-318.52M | $-458.45M | $-610.55M | $-828.42M | $-1.03B | $-1.24B | $-1.32B |
| Accounts receivable | $723000.00 | $2.35M | $5.42M | $12.10M | $25.43M | $28.55M | $40.29M | $44.06M | $34.90M | $57.02M |
| Inventory | $1.23M | $1.83M | $6.03M | $7.33M | $12.29M | $31.80M | $39.31M | $32.06M | $24.08M | $28.31M |
| Goodwill | $1.14M | $1.14M | $1.14M | $1.14M | $1.14M | $22.43M | $85.81M | $85.81M | $85.81M | $82.19M |